Here you'll find the latest press releases on VIB research and other important news.
EMBO is an organization that unites leading researchers in the life sciences to promotes scientific excellence. Every year, new members are selected from among Europe’s top-scientists. This year, Jean-Christophe Marine (VIB-KU Leuven), Jan Steyaert (VIB-VUB), and Alain Goossens (VIB-UGent) join the other VIB EMBO members.
Every five years, the Research Foundation Flanders (FWO) awards the prestigious Excellence Prizes to eminent Flemish researchers with a distinguished career in science. In 2020, two VIB researchers working at Ghent University have received this important recognition for their outstanding scientific career and dedication to research: Prof. Bart Lambrecht (VIB-UGent Center for Inflammation Research) and prof. Wout Boerjan (VIB-UGent Center for Plant Systems Biology).
In recognition of his outstanding work in rheumatology, Prof. Dirk Elewaut (VIB-UGent Center for Inflammation Research and Ghent University Hospital) is the first Belgian scientist to receive the Carol Nachman prize. This award is considered as the world’s highest honor awarded to a rheumatologist.
Two mutations identified in individuals with developmental and epileptic brain disease can be traced back to the same ion channel. Researchers have now elucidated how both independent mutations affect the channel’s function: by making it overly active and highly sensitive to stimulation. The findings are an important step towards unraveling what causes the patients’ symptoms.
A collaborative study by research groups from the VIB-UGent Center for Inflammation Research and Ghent University uncovered a new mechanism causing colorectal cancer. The researchers found that abnormal expression of the protein Zeb2 affects the integrity of the intestinal wall or ‘epithelium’.
Leuven researchers have deployed synthetic amyloids to trigger protein misfolding as a strategy to combat the influenza A and Zika virus.
In a recent study in JAMA Neurology, a Leuven research team led by Prof. Philip Van Damme, reveals that FDG-PET imaging is an early and sensitive biomarker to detect cerebral metabolic changes in presymptomatic carriers of a C9orf72 mutation. Their findings suggest that FDG-PET captures early cerebral changes years before disease onset.
The Chan Zuckerberg Initiative announced $3.8 million in funding for 23 grants to support open-source software projects essential to biomedical research. Software by the lab of Yvan Saeys (VIB-UGent) for the analysis and visualization of single-cell data is one of the projects that will receive funding as part of CZI’s Essential Open Source Software for Science (EOSS) program.
Single cell technologies provide unprecedented insights into the dynamics of gene regulation of individual cells, but resolving spatiotemporal regulation networks has remained an experimental and computational challenge. A team of scientists lead by Stein Aerts (VIB-KU Leuven) came up with a new approach to map gene regulation in 2D tissues.
Ghent, May 14, 2020. A team of VIB researchers led by Dr Hilde Nelissen and Prof Dirk Inzé are starting a field trial today with a maize variety that is better adapted to drought.
With a discovery that could rewrite the immunology textbooks, an international group of scientists, including the teams of Bart Lambrecht, Martin Guilliams, Hamida Hammad, and Charlotte Scott (all from the VIB-UGent Center for Inflammation Research) identified a new type of antigen-presenting immune cell.
In 2012, the European Union MetaCardis consortium, comprising 14 research groups from six European countries with multidisciplinary expertise set out to investigate a potential role of the gut microbiota in the development of cardio-metabolic diseases.
The lab of Xavier Saelens (VIB-UGent Center for Medical Biotechnology) announces the isolation and characterization of a unique antibody that can bind to the virus that causes COVID-19 (SARS-CoV-2). The antibody was described in collaboration with research groups in the US.
Under the guidance of an internal taskforce, VIB has leveraged its experience as leading life sciences institute to contribute to upscaling the COVID-19 testing capacity.
During the past years, VIB was led by a duo of managing directors, Jo Bury and Johan Cardoen. Johan Cardoen, who also led the VIB’s Innovation & Business team has recently decided to step down from his executive functions for health reasons. After an intensive selection procedure, Jérôme Van Biervliet has been selected as new managing director of VIB alongside Jo Bury.